Page last updated: 2024-08-17

levodopa and Melanoma

levodopa has been researched along with Melanoma in 121 studies

Research

Studies (121)

Timeframe	Studies, this research(%)	All Research%
pre-1990	67 (55.37)	18.7374
1990's	23 (19.01)	18.2507
2000's	17 (14.05)	29.6817
2010's	12 (9.92)	24.3611
2020's	2 (1.65)	2.80

Authors

Authors	Studies
Fujita, K; Inoue, S; Ito, S; Yamamoto, Y	1
Guillén Climent, S; Monteagudo, C; Pinazo Canales, MI; Porcar Saura, S	1
Cardoso, R; da S Gonçalves Vianez, JL; de Molfetta, FA; Nahum Alves, C; Santana da Costa, K; Souza da Costa, CH; Valente, R	1
Jeong, H; Kim, D; Kim, K; Leutou, AS; Lim, KM; Nam, SJ; Seong, CN	1
Almeida, MA; Chaves, OA; de Oliveira, MCC; Echevarria, A; Marins-Goulart, C; Soares, MA	1
Bakker, WJ; Kammeyer, A; Luiten, RM; Ouwerkerk, W; Pronk, SD; Ratsma, D; Smit, NPM; Willemsen, KJ	1
Mansouri, K; Razlansari, M; Shahabadi, N; Zhaleh, H	1
Barth, RF; Chandra, S; Haider, SA; Huo, T; Kabalka, GW; Shaikh, AL; Yang, W	1
Bhin, J; Bin, BH; Cho, EG; Choi, DH; Hwang, D; Lee, AY; Lee, TR; Park, K; Shin, DW; Yang, SH	1
Disse, M; Lee, PK; Reich, H; Schram, SS	1
Trip, J; Vermeij, JD; Weber, WE; Winogrodzka, A	1
Charles, J; Lantuejoul, S; Leccia, MT; Leroux, D; Robert, C; Salameire, D; Templier, I	1
Inzelberg, R; Israeli-Korn, SD	1
Houlden, H; Paisán-Ruiz, C	1
Kawano, Y; Yamazaki, Y	1
Gao, X; Ning, Y	1
Pawelek, J; Slominski, A; Zmijewski, MA	1
Che, CT; Cheung, FWK; Guo, J; Ling, YH; Liu, WK	1
Bousquet, B; Garnier, JP; Ghanem, G; Le Bricon, T; Letellier, S; Morel, P; Stoitchkov, K; Tsankov, N	2
Fiala, KH; Manyam, BV; Whetteckey, J	1
Loria, D; Rosso, S; Zanetti, R	1
Bressac de Paillerets, B; Charles, J; Combe, MC; Leccia, MT; Leroux, D; Templier, I	1
Rosso, S; Zanetti, R	1
Baccard, M; Basset-Seguin, N; Bousquet, B; Cassinat, B; Dubertret, L; Garnier, JP; Kerob, D; Le Bricon, T; Lebbé, C; Letellier, S; Morel, P; Stoitchkov, K	1
Constantinescu, R; Kieburtz, K; Romer, M	1
Avril, MF; Bonadona, V; Bressac-de Paillerets, B; Chompret, A; Dalle, S; Kannengiesser, C; Lasset, C; Leccia, MT; Lenoir, G; Leroux, D; Lesueur, F; Sarasin, A; Thomas, L	1
Frederiksen, K; Friis, S; Olsen, JH; Tangerud, K; Wermuth, L	1
Loria, DI; Rosso, S; Zanetti, R	1
Boekelheide, K; Graham, DG; Koo, EH; Mize, PD	1
Hakim, AA	1
Busse, E; Riessbeck, KH; Rose, H	1
Jergil, B; Lindbladh, C; Rorsman, H; Rosengren, E	1
Fitzpatrick, TB; Harrist, TJ; Melski, JW; Mihm, MC; Rhodes, AR; Sober, AJ	1
DiSorbo, DM; Harris, NA; Nathanson, L	1
Lukács, L; Menyhei, G; Péter, S	1
Blagoeva, PM	1
Celis, JE	1
Hendrix, MJ; Meyskens, FL; Persky, B	1
Bomirski, A; Scisłowski, PW; Słomiński, A	1
Braun, M; Rosin, MA	1
Wick, MM	6
Lubahn, DB; McCarty, KS; Seigler, HF; Stowers, S; Wortman, J	1
Fujita, K; Ito, S; Teradaira, R	1
Meadows, GG; Pierson, HF	2
Ali, FM; Black, M; Camp, VM; Faraj, BA; Lawson, DH; Murray, DR; Nixon, DW; Stacciarini, W; Tarcan, Y	1
Krummel, TM; Neifeld, JP; Taub, RN	1
Thiers, BH	1
Abdallah, RM; Desai, PR; Meadows, GG; Pierson, HF	1
Brihaye-Van Geertruyden, MF; De Jong, PT; Demols, EE; Van Rens, GH	1
Bowers, RR; Hadfield, TL; Shieh, SJ	1
Gilbert, EF; Ramirez, G; Warner, TF	1
Bernstein, JE; Lorincz, AL; Medenica, M; Solomon, A; Soltani, K	1
Karhunen, T; Pavel, S; Slingerland, R; Smit, N; Tilgmann, C; Ulmanen, I; Westerhof, W	1
Arakawa, H; Funayama, M; Murao, S; Nishino, T; Shin, T; Yamamoto, R	1
Fujita, K; Hasegawa, K; Inoue, S; Ito, S; Jiménez-Cervantes, C; Ozeki, H; Solano, F; Wakamatsu, K	1
Goldenberg, JN; Sanchez-Ramos, JR; Singer, C; Weiner, WJ	1
Larsson, BS; Mårs, U	1
Burg, G; Kleinhans, M; Schmid-Grendelmeier, P	1
Pfützner, W; Przybilla, B	1
Bousquet, B; Garnier, JP; Letellier, S; Spy, J	1
Manyam, BV; Woofter, MJ	1
Michiels, JF; Ortonne, JP; Perrin, C; Pisani, A	1
Rampen, F	1
Baccard, M; Bousquet, B; Garnier, JP; Kerneis, Y; Le Bricon, T; Letellier, S; Revol, M; Spy, J; Stoitchkov, K	1
Dizdar, N; Granérus, AK; Hannestad, U; Kågedal, B; Kullman, A; Ljungdahl, A; Olsson, JE	1
Rosenblatt, BK; Schneider, DC; Siple, JF; Wanlass, WA	1
Borel Rinkes, IH; Hamoen, KE; Morgan, JR	1
Clement, MV; Halliwell, B; Long, LH; Ramalingam, J	1
Li, JP; Pomerantz, SH	1
Delaney, P; Fermaglich, J	2
Cogniaux, J; Doyen, A; Frühling, J; Liteanu, D; Van Tieghem, N	1
Yahr, MD	1
Lee, MS; Lee, TH	1
Borovanský, J; Duchon, J; Pavel, S; Vulterin, K	1
Gorman, M; Kramer, RA; Wick, MM	1
Sober, AJ; Wick, MM	1
Botteri, A; Nordström, PO	1
Maat, B	1
Frei, E; Wick, MM	1
Byers, L; Frei, E; Wick, MM	1
Bornstein, B; Kott, E; Shohat, B	1
Pelfréne, AF	1
Haider, SA; Thaller, VT	1
Pruski, D; Slominski, A	1
Esteguy, M; Leiguarda, R; Merello, M; Perazzo, F	1
Schallreuter, KU; Wood, JM	1
Karg, E; Rorsman, H; Rosengren, E	1
Costantino, R; Slominski, A	1
Slominski, A	1
D'iakov, VL; Iakh''iaev, AV; Lalaev, VV; Sukhanov, VA	1
Coates, A; Gurney, H; Kefford, R	1
Ito, S; Kasuga, T; Matsubara, O; Seki, S; Suzuki, S; Yamada, I	2
Braun-Falco, O; Landthaler, M; Przybilla, B; Schwab, U	1
Kande'l, EI	1
Favier, D; Kable, EP; Parsons, PG	1
McLane, J; Osber, M; Pawelek, JM	1
Kable, EP; Parsons, PG	1
Murray, M; Pawelek, JM	1
Breathnach, A; Faggioni, A; Nazzaro-Porro, M; Passi, S; Picardo, M; Riley, P; Zompetta, C	1
Maggini, M; Morpurgo, G	1
Bomirski, A; Kuklinska, E; Moellmann, G; Pawelek, J; Słominski, A	1
Aime, S; Crippa, PR	1
Fukunaga, M; Furukawa, T; Kawada, M; Mitsumori, M; Muranaka, A; Nagai, K; Ono, S; Otsuka, N; Tomomitsu, T; Yanagimoto, S	1
Abdallah, RM; Meadows, GG; Starkey, JR	1
Berjian, RA; Bhakoo, HS; Kanter, PM; Lawrence, DD; Tan, MH	1
García-Borrón, JC; Iborra, JL; Lozano, JA; Martínez, JH; Solano, F	1
Camp, VM; Faraj, BA; Hearn, J; Kutner, M; Murray, DR; Nixon, D	1
Rampen, FH	1
Kochar, AS	1
Castagnoli, N; Epstein, WL; Fukuyama, K; Gellin, GA; Halldin, MM; Kawashima, T	1
Bomirski, A; Scisłowski, PW; Słomiński, A; Zydowo, M	1

Reviews

14 review(s) available for levodopa and Melanoma

Article	Year
A Review of the Association Between Parkinson Disease and Malignant Melanoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2016, Volume: 42, Issue:2 Topics: Antiparkinson Agents; Environment; Genetic Predisposition to Disease; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms; Skin Pigmentation	2016
Parkinson's disease, levodopa-use and the risk of melanoma. Parkinsonism & related disorders, 2009, Volume: 15, Issue:8 Topics: Animals; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms	2009
The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:11 Topics: Antiparkinson Agents; Causality; Comorbidity; Humans; Levodopa; Mass Screening; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms	2009
Cancer and Parkinson's disease: the odd couple. Drugs of today (Barcelona, Spain : 1998), 2011, Volume: 47, Issue:3 Topics: Humans; Levodopa; Life Style; Melanoma; Neoplasms; Parkinson Disease; Smoking; Social Class	2011
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment cell & melanoma research, 2012, Volume: 25, Issue:1 Topics: Animals; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Models, Biological; Monophenol Monooxygenase; Oxidative Stress; Skin Neoplasms; Structure-Activity Relationship; Tyrosine	2012
Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence? Parkinsonism & related disorders, 2003, Volume: 9, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Retrospective Studies; Skin Neoplasms	2003
Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Melanoma research, 2006, Volume: 16, Issue:3 Topics: Animals; Humans; Levodopa; Melanoma; Mice; Parkinson Disease; Skin Neoplasms	2006
Parkinson's disease and cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2007, Volume: 16, Issue:6 Topics: Antiparkinson Agents; Cohort Studies; Humans; Levodopa; Melanoma; Neoplasms; Parkinson Disease	2007
Levodopa, melanoma, and Parkinson's disease. Neurology, 1993, Volume: 43, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Contraindications; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Parkinson Disease; Skin Neoplasms	1993
[Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1996, Volume: 47, Issue:6 Topics: Aged; Antiparkinson Agents; Cell Transformation, Neoplastic; Humans; Levodopa; Long-Term Care; Male; Melanoma; Parkinson Disease; Skin; Skin Neoplasms	1996
Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature. Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:2 Pt 2 Topics: Aged; Antiparkinson Agents; Back; Biopsy; Humans; Levodopa; Male; Melanoma; Middle Aged; Nose Neoplasms; Parkinson Disease; Skin; Skin Neoplasms	1997
Levodopa therapy and the risk of malignant melanoma. The Annals of pharmacotherapy, 2000, Volume: 34, Issue:3 Topics: Antiparkinson Agents; Humans; Levodopa; Melanoma; Parkinson Disease	2000
Levodopa. Annals of internal medicine, 1975, Volume: 83, Issue:5 Topics: Benserazide; Drug Interactions; Hepatic Encephalopathy; Humans; Huntington Disease; Levodopa; Melanoma; Parkinson Disease; Pituitary Function Tests	1975
[Melanoma as a possible complication of the treatment of parkinsonism with L-dopa preparations (review of the literature)]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1989, Volume: 89, Issue:9 Topics: Humans; Levodopa; Melanoma; Parkinson Disease; Skin Neoplasms	1989

Trials

1 trial(s) available for levodopa and Melanoma

Article	Year
Treatment with levodopa and risk for malignant melanoma. Movement disorders : official journal of the Movement Disorder Society, 2007, Jul-15, Volume: 22, Issue:9 Topics: Antiparkinson Agents; Case-Control Studies; Female; Follow-Up Studies; Humans; Incidence; Levodopa; Male; Melanoma; Odds Ratio; Parkinson Disease; Retrospective Studies; Risk	2007

Other Studies

106 other study(ies) available for levodopa and Melanoma

Article	Year
Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds. Journal of medicinal chemistry, 1981, Volume: 24, Issue:6 Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cricetinae; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Leukemia L1210; Male; Melanoma; Mice; Neoplasms, Experimental; Neuroblastoma	1981
Melanocytic Hyperactivation Simulating an Acral Lentiginous Melanoma in a Patient With Parkinson Disease Treated by Levodopa. The American Journal of dermatopathology, 2021, Mar-01, Volume: 43, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Diagnosis, Differential; Drug Combinations; Female; Humans; Hyperpigmentation; Levodopa; Melanins; Melanocytes; Melanoma; Parkinson Disease; Predictive Value of Tests; Skin; Skin Neoplasms; Skin Pigmentation; Treatment Outcome	2021
Analysis of Kojic Acid Derivatives as Competitive Inhibitors of Tyrosinase: A Molecular Modeling Approach. Molecules (Basel, Switzerland), 2021, May-12, Volume: 26, Issue:10 Topics: Catalytic Domain; Enzyme Inhibitors; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Monophenol Monooxygenase; Pyrones; Skin Neoplasms; Structure-Activity Relationship; Tyrosine	2021
Anti-Pigmentary Effect of (-)-4-Hydroxysattabacin from the Marine-Derived Bacterium Bacillus sp. Marine drugs, 2017, May-13, Volume: 15, Issue:5 Topics: Animals; Aquatic Organisms; Bacillus; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Epidermis; Hexanones; Humans; Levodopa; Melanins; Melanoma; Mice; Molecular Structure; Pigmentation	2017
Thiosemicarbazones as inhibitors of tyrosinase enzyme. Bioorganic & medicinal chemistry letters, 2017, 08-01, Volume: 27, Issue:15 Topics: Agaricales; Enzyme Inhibitors; Humans; Levodopa; Melanins; Melanoma; Molecular Docking Simulation; Monophenol Monooxygenase; Thiosemicarbazones	2017
Mechanism of action of 4-substituted phenols to induce vitiligo and antimelanoma immunity. Pigment cell & melanoma research, 2019, Volume: 32, Issue:4 Topics: Biological Assay; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Humans; Immunity; Levodopa; Lymphocyte Activation; Melanins; Melanoma; Melanosomes; Monophenol Monooxygenase; Phenols; Protein Binding; Quinones; Sulfhydryl Compounds; Vitiligo	2019
Antiproliferative effects of new magnetic pH-responsive drug delivery system composed of Fe Materials science & engineering. C, Materials for biological applications, 2019, Volume: 101 Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Hydroxides; Levodopa; Melanoma	2019
Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2014, Volume: 88 Topics: Animals; Boron Compounds; Brain Neoplasms; Drug Synergism; Female; Glioma; Levodopa; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Organ Specificity; Phenylalanine; Premedication; Tissue Distribution; Treatment Outcome	2014
Hyperosmotic stress reduces melanin production by altering melanosome formation. PloS one, 2014, Volume: 9, Issue:8 Topics: Antiparkinson Agents; Blotting, Western; Cell Line, Tumor; Cluster Analysis; Gene Expression Profiling; gp100 Melanoma Antigen; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Melanosomes; Membrane Glycoproteins; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Oligonucleotide Array Sequence Analysis; Osmotic Pressure; Oxidoreductases; Phosphatidylinositol 3-Kinases; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Vacuoles	2014
Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease. Pigment cell & melanoma research, 2009, Volume: 22, Issue:6 Topics: DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Skin Neoplasms; Ultraviolet Rays	2009
Common pathogenic pathways in melanoma and Parkinson disease. Neurology, 2010, Nov-02, Volume: 75, Issue:18 Topics: Brain Neoplasms; Group VI Phospholipases A2; Humans; Levodopa; Melanoma; Neural Pathways; Parkinson Disease; Tyrosine	2010
N-(3,5-dihydroxybenzoyl)-6-hydroxytryptamine as a novel human tyrosinase inhibitor that inactivates the enzyme in cooperation with l-3,4-dihydroxyphenylalanine. Chemical & pharmaceutical bulletin, 2010, Volume: 58, Issue:11 Topics: Cell Line, Tumor; Enzyme Inhibitors; Humans; Levodopa; Melanoma; Monophenol Monooxygenase; Serotonin	2010
Anti-melanogenic property of geoditin A in murine B16 melanoma cells. Marine drugs, 2012, Volume: 10, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum; Geodia; Glycosylation; Inhibitory Concentration 50; Levodopa; Lysosomes; Melanins; Melanoma; Mice; Monophenol Monooxygenase; Neoplasm Proteins; Protein Processing, Post-Translational; Reactive Oxygen Species; Resorcinols; Triterpenes	2012
Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B. Melanoma research, 2002, Volume: 12, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bulgaria; Chromatography, High Pressure Liquid; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Nerve Growth Factors; Predictive Value of Tests; Prognosis; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tyrosine	2002
Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker. Melanoma research, 2003, Volume: 13, Issue:6 Topics: Adult; Biomarkers, Tumor; Cell Line, Tumor; Chromatography, High Pressure Liquid; Female; Humans; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nerve Growth Factors; Prognosis; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors; Tyrosine	2003
[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma]. Annales de dermatologie et de venereologie, 2006, Volume: 133, Issue:10 Topics: Antiparkinson Agents; Cyclin-Dependent Kinase Inhibitor p16; Genes, p16; Humans; Levodopa; Male; Melanoma; Middle Aged; Mutation; Skin Neoplasms	2006
Levodopa and the risk of melanoma. Lancet (London, England), 2007, Jan-27, Volume: 369, Issue:9558 Topics: Antiparkinson Agents; Case-Control Studies; Humans; Levodopa; Melanoma; Parkinson Disease; Registries; Risk Factors; Smoking	2007
Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma. European journal of cancer (Oxford, England : 1990), 2007, Volume: 43, Issue:4 Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Prospective Studies; S100 Proteins; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tyrosine	2007
Malignant melanoma in early Parkinson's disease: the DATATOP trial. Movement disorders : official journal of the Movement Disorder Society, 2007, Apr-15, Volume: 22, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cohort Studies; Comorbidity; Cross-Sectional Studies; Female; Humans; Incidence; Levodopa; Male; Melanoma; Middle Aged; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Reference Values; Retrospective Studies; Skin Neoplasms	2007
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment. Genes, chromosomes & cancer, 2007, Volume: 46, Issue:8 Topics: DNA Mutational Analysis; Family; Family Health; Founder Effect; France; Gene Frequency; Genes, p16; Germ-Line Mutation; Haplotypes; Humans; Levodopa; Melanoma; Pedigree	2007
Melanocytotoxicity and the mechanism of activation of gamma-L-glutaminyl-4-hydroxybenzene. The Journal of investigative dermatology, 1980, Volume: 75, Issue:4 Topics: Aminophenols; Animals; Cattle; Enzyme Activation; gamma-Glutamyltransferase; Glutamine; Hydroxylation; Levodopa; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Tritium	1980
Correlation between tyrosine hydroxylase activity, melanogenesis, and estradiol binding in human melanoma cells. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1982, Volume: 180, Issue:2 Topics: Breast Neoplasms; Cell Line; Cytosol; Estradiol; Fibroblasts; Humans; Kinetics; Levodopa; Melanins; Melanoma; Tamoxifen; Tyrosine; Tyrosine 3-Monooxygenase	1982
[Effect of the cAMP and interferon levels in the lymphocytes and on a change in the tumor growth rate of a transplantable golden hamster melanoma after BCG, measles vaccine, L-DOPA and amantadine treatment]. Radiobiologia, radiotherapia, 1980, Volume: 21, Issue:3 Topics: Amantadine; Animals; BCG Vaccine; Cricetinae; Cyclic AMP; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Interferons; Levodopa; Lymph Nodes; Lymphocytes; Measles Vaccine; Melanoma; Mesocricetus; Neoplasm Transplantation; Neoplasms, Experimental	1980
Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine. Acta dermato-venereologica, 1984, Volume: 64, Issue:2 Topics: Catalase; Catechol Oxidase; Cells, Cultured; Cysteine; Humans; In Vitro Techniques; Levodopa; Melanoma; Monophenol Monooxygenase; Superoxide Dismutase; Tyrosine	1984
Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines. The Journal of investigative dermatology, 1983, Volume: 80, Issue:5 Topics: Adult; Aged; Female; Histological Techniques; Humans; Lentigo; Levodopa; Male; Melanocytes; Melanoma; Middle Aged; Nevus; Paraffin; Skin; Skin Neoplasms	1983
Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell line. Cancer research, 1984, Volume: 44, Issue:5 Topics: Carbon Radioisotopes; Catechol Oxidase; Cell Cycle; Cell Line; DNA Replication; Humans; Kinetics; Levodopa; Melanoma; Monophenol Monooxygenase; Triamcinolone Acetonide; Tritium; Tyrosine	1984
[Serum L-DOPA oxidase activity in patients with malignant cutaneous melanoma]. Orvosi hetilap, 1984, Oct-07, Volume: 125, Issue:41 Topics: Adult; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Oxidoreductases; Skin Neoplasms	1984
Aminoacids--precursors of melanin synthesis in hamster melanoma. Journal of cancer research and clinical oncology, 1984, Volume: 108, Issue:3 Topics: Amino Acids; Animals; Cricetinae; Ferrous Compounds; Iron; Levodopa; Male; Melanins; Melanoma; Mesocricetus; Neoplasm Transplantation; Phenylalanine; Tryptophan; Tyrosine	1984
Expression of mRNAs microinjected into somatic cells. Ciba Foundation symposium, 1984, Volume: 103 Topics: Animals; Cell Division; Cells, Cultured; Globins; Levodopa; Melanins; Melanoma; Mice; Microinjections; Protein Biosynthesis; RNA, Messenger	1984
Diagnostic electron microscopy for amelanotic melanoma: correlation of patient biopsy, soft agar assay, and xenograft. The Journal of pathology, 1983, Volume: 141, Issue:1 Topics: Adult; Agar; Animals; Biopsy; Cells, Cultured; Humans; Levodopa; Male; Melanoma; Mice; Mice, Nude; Microscopy, Electron; Neoplasm Transplantation; Transplantation, Heterologous	1983
Biochemical characterization of three hamster melanoma variants--II. Glycolysis and oxygen consumption. The International journal of biochemistry, 1984, Volume: 16, Issue:3 Topics: Animals; Cricetinae; Glycolysis; Lactates; Levodopa; Melanoma; Mesocricetus; Neoplasm Transplantation; Oxygen Consumption	1984
Malignant melanoma and levodopa. Cutis, 1984, Volume: 33, Issue:6 Topics: Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Nevus; Skin Neoplasms	1984
Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer research, 1980, Volume: 40, Issue:5 Topics: Animals; Cell Membrane Permeability; Cells, Cultured; DNA, Neoplasm; Dopamine; Humans; Levodopa; Melanoma; Mice; Monophenol Monooxygenase; Neoplasms, Experimental; Nucleic Acid Synthesis Inhibitors; Quinones	1980
Sex steroid receptor analysis in human melanoma. Cancer, 1980, Sep-15, Volume: 46, Issue:6 Topics: Adult; Aged; Estradiol; Estrogen Antagonists; Female; Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Monophenol Monooxygenase; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Tyrosine	1980
Distribution and metabolism of tritiumlabelled 5-S-cysteinyldopa in mice. Biochemical pharmacology, 1980, Volume: 29, Issue:24 Topics: Animals; Cysteinyldopa; Dihydroxyphenylalanine; Levodopa; Male; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Tissue Distribution	1980
Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma. Cancer research, 1983, Volume: 43, Issue:5 Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Carbidopa; Cell Line; Diet; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Tyrosine	1983
The chemotherapy of malignant melanoma. The Journal of investigative dermatology, 1983, Volume: 80 Suppl Topics: Carbidopa; Cardiovascular Diseases; Dopamine; Drug Evaluation; Humans; Levodopa; Melanoma; Mitotic Index; Skin Neoplasms	1983
Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine. Clinical chemistry, 1981, Volume: 27, Issue:1 Topics: Adolescent; Adult; Aged; Deoxyepinephrine; Dopamine; Female; Humans; Immunoenzyme Techniques; Levodopa; Male; Melanoma; Middle Aged; Radioimmunoassay	1981
Effects of dopamine agonists and antagonists on murine melanoma: correlation with dopamine binding activity. Cancer, 1982, Mar-15, Volume: 49, Issue:6 Topics: Animals; Binding, Competitive; Cell Line; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Levodopa; Melanoma; Mice; Neoplasms, Experimental; Pimozide	1982
Chemotherapy of malignant melanoma. Journal of the American Academy of Dermatology, 1982, Volume: 6, Issue:3 Topics: Daunorubicin; Dicarboxylic Acids; Drug Combinations; Drug Resistance; Humans; Levodopa; Melanocyte-Stimulating Hormones; Melanoma; Methotrexate; Nitrosourea Compounds; Receptors, Estrogen; Tretinoin	1982
Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy. Cancer research, 1982, Volume: 42, Issue:8 Topics: Animals; Carbidopa; Diet; Drug Evaluation, Preclinical; Female; Levodopa; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine	1982
Uveal malignant melanoma and levodopa therapy in Parkinson's disease. Ophthalmology, 1982, Volume: 89, Issue:12 Topics: Aged; Ciliary Body; Female; Humans; Levodopa; Melanoma; Middle Aged; Parkinson Disease; Uveal Neoplasms	1982
An ultrastructural study of albinistic B-14 melanoma cells. Experimental and molecular pathology, 1981, Volume: 35, Issue:1 Topics: Animals; Cell Line; Chromatography, Thin Layer; Culture Media; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Electron; Neoplasms, Experimental; Pigmentation; Tyrosine	1981
An experimental approach to the chemotherapy of melanoma. The Journal of investigative dermatology, 1980, Volume: 74, Issue:2 Topics: Antineoplastic Agents; Dopamine; Humans; Indoles; Levodopa; Melanins; Melanoma; Skin Neoplasms; Tyrosine	1980
Epidermotropism in melanoma. Journal of cutaneous pathology, 1980, Volume: 7, Issue:1 Topics: Epidermis; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Nevus; Skin; Skin Neoplasms; Time Factors	1980
Levodopa administration and multiple primary cutaneous melanomas. Archives of dermatology, 1980, Volume: 116, Issue:9 Topics: Aged; Female; Humans; Levodopa; Melanoma; Neoplasms, Multiple Primary; Skin Neoplasms; Tremor	1980
O-methylation of L-dopa in melanin metabolism and the presence of catechol-O-methyltransferase in melanocytes. Pigment cell research, 1994, Volume: 7, Issue:6 Topics: 1-Methyl-3-isobutylxanthine; Catechol O-Methyltransferase; Cells, Cultured; Humans; Isoenzymes; Levodopa; Melanins; Melanocytes; Melanoma; Membrane Proteins; Methylation; Microscopy, Immunoelectron; Monophenol Monooxygenase; Neoplasm Proteins; Subcellular Fractions; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured	1994
Effects of alpha- and beta-arbutin on activity of tyrosinases from mushroom and mouse melanoma. Bioscience, biotechnology, and biochemistry, 1995, Volume: 59, Issue:1 Topics: Animals; Arbutin; Basidiomycota; Binding, Competitive; Chromatography, High Pressure Liquid; Hydroquinones; Levodopa; Magnetic Resonance Spectroscopy; Melanoma; Mice; Monophenol Monooxygenase; Starch	1995
Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol. Cancer research, 1995, Jun-15, Volume: 55, Issue:12 Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Division; Cell Line; Cell Survival; Cysteamine; Dose-Response Relationship, Drug; Humans; Kinetics; Levodopa; Melanoma; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Monophenol Monooxygenase; Oxidation-Reduction; Oxidoreductases; Proteins; Tumor Cells, Cultured	1995
New thioureas and related substances intended for melanoma targeting. Pigment cell research, 1995, Volume: 8, Issue:4 Topics: Animals; Autoradiography; Basidiomycota; Benzoquinones; Dihydroxyphenylalanine; Dopamine Agents; Intramolecular Oxidoreductases; Isomerases; Levodopa; Melanins; Melanoma; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Neoplasm Transplantation; Oxidation-Reduction; Thiourea; Whole-Body Irradiation	1995
Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma. Journal of chromatography. B, Biomedical sciences and applications, 1997, Aug-15, Volume: 696, Issue:1 Topics: Biomarkers, Tumor; Calibration; Chromatography, High Pressure Liquid; Circadian Rhythm; Humans; Hydrogen-Ion Concentration; Levodopa; Linear Models; Melanins; Melanoma; Reproducibility of Results; Skin Neoplasms; Spectrometry, Fluorescence; Tyrosine	1997
Safety of long-term levodopa therapy in malignant melanoma. Clinical neuropharmacology, 1994, Volume: 17, Issue:4 Topics: Aged; Antiparkinson Agents; Drug Administration Schedule; Humans; Levodopa; Male; Melanoma; Parkinson Disease	1994
Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation. The American Journal of dermatopathology, 1997, Volume: 19, Issue:5 Topics: Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Cell Count; Cell Differentiation; Coloring Agents; Dopamine Agents; Epidermal Cells; Epithelial Cells; Female; Humans; Immunohistochemistry; Levodopa; Male; Melanins; Melanocytes; Melanoma; Melanoma-Specific Antigens; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Nail Diseases; Nails; Neoplasm Proteins; Oxidoreductases; Pigmentation Disorders; Proteins; Vacuoles	1997
Melanoma and levodopa. Journal of the American Academy of Dermatology, 1998, Volume: 38, Issue:5 Pt 1 Topics: Antiparkinson Agents; Dopamine Agonists; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms	1998
Development of metastases in malignant melanoma is associated with an increase in the plasma L-dopa/L-tyrosine ratio. Melanoma research, 1999, Volume: 9, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Humans; Levodopa; Longitudinal Studies; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Reference Values; Skin Neoplasms; Tyrosine	1999
L-dopa pharmacokinetics studied with microdialysis in patients with Parkinson's disease and a history of malignant melanoma. Acta neurologica Scandinavica, 1999, Volume: 100, Issue:4 Topics: Aged; Antiparkinson Agents; Benserazide; Female; Humans; Levodopa; Male; Melanoma; Microdialysis; Middle Aged; Parkinson Disease; Skin Neoplasms	1999
Hepatocyte growth factor and melanoma: gene transfer studies in human melanocytes. Melanoma research, 2001, Volume: 11, Issue:2 Topics: Cell Differentiation; Cell Division; Cell Transformation, Neoplastic; DNA, Complementary; Gene Transfer Techniques; Genetic Therapy; Hepatocyte Growth Factor; Humans; Immunohistochemistry; Levodopa; Melanocytes; Melanoma; Microscopy, Phase-Contrast; Phenotype; Retroviridae; Time Factors; Transduction, Genetic; Tumor Cells, Cultured	2001
The cytotoxicity of dopamine may be an artefact of cell culture. Journal of neurochemistry, 2002, Volume: 81, Issue:3 Topics: Animals; Artifacts; Catalase; Cell Death; Culture Media; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Glutathione; Humans; Hydrogen Peroxide; Levodopa; Melanoma; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Nerve Tissue Proteins; Oxidants; Oxidation-Reduction; PC12 Cells; Pheochromocytoma; Rats; Tumor Cells, Cultured	2002
Tyrosine aminotransferase in AKR/J albino and C57BL/6J black mouse skin. The Journal of investigative dermatology, 1978, Volume: 70, Issue:5 Topics: Amino Acid Oxidoreductases; Animals; Cricetinae; In Vitro Techniques; Kinetics; Levodopa; Melanoma; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Molecular Weight; Phenylpyruvic Acids; Pigmentation; Skin; Species Specificity; Substrate Specificity; Tyrosine Transaminase	1978
Parkinson's disease, melanoma, and levodopa. Journal of neurology, 1977, Jun-13, Volume: 215, Issue:3 Topics: Aged; Humans; Levodopa; Male; Melanoma; Parkinson Disease; Skin Neoplasms	1977
Modulation of tyrosinase activity and viral information by 5-iodo-deoxyuridine and L-dopa in a human melanoma cell line [proceedings]. Archives internationales de physiologie et de biochimie, 1979, Volume: 87, Issue:4 Topics: Animals; Antigens, Viral; Catechol Oxidase; Cell Line; Humans; Idoxuridine; Levodopa; Magnesium; Melanoma; Mice; Monophenol Monooxygenase; Neoplasms, Experimental; Oncogenic Viruses; RNA-Directed DNA Polymerase	1979
Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro. Acta endocrinologica, 1977, Volume: 84, Issue:3 Topics: Animals; Catechol Oxidase; Cells, Cultured; In Vitro Techniques; Levodopa; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Mice; Monophenol Monooxygenase; Neoplasms, Experimental; Puromycin; Tyrosine	1977
Incorporation of L-3,4-dihydroxy-[2-14C]phenylalanine into hamster melanoma melanosomes. FEBS letters, 1979, Aug-15, Volume: 104, Issue:2 Topics: Animals; Carbon Radioisotopes; Cell Fractionation; Cricetinae; Levodopa; Melanocytes; Melanoma; Mesocricetus; Neoplasms, Experimental	1979
Enhancement of L-dopa incorporation into melanoma by dopa decarboxylase inhibition. The Journal of investigative dermatology, 1978, Volume: 70, Issue:6 Topics: Adrenal Medulla; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Catecholamines; Levodopa; Melanins; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Rats	1978
Levodopa therapy and malignant melanoma. JAMA, 1978, Aug-11, Volume: 240, Issue:6 Topics: Adult; Age Factors; Aged; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Skin Neoplasms	1978
[Connection between levodopa therapy and malignant tumors]. Lakartidningen, 1979, Jan-31, Volume: 76, Issue:5 Topics: Aged; Female; Humans; Levodopa; Melanoma; Urethral Neoplasms	1979
Levodopa and melanoma. JAMA, 1979, Mar-02, Volume: 241, Issue:9 Topics: Humans; Levodopa; Melanoma; Parkinson Disease; Skin Neoplasms	1979
Pigmented hyperplasia of epidermis following feeding of L-dopa to elderly rats. Journal of the National Cancer Institute, 1977, Volume: 58, Issue:5 Topics: Age Factors; Animals; Humans; Hyperplasia; Levodopa; Male; Melanins; Melanoma; Neoplasms, Experimental; Pigmentation; Precancerous Conditions; Rats; Rats, Inbred BN; Recurrence; Skin; Skin Neoplasms	1977
Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro. Cancer research, 1977, Volume: 37, Issue:7 Pt 1 Topics: Cells, Cultured; Cycloheximide; Levodopa; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Neoplasms, Experimental; Theophylline; Tyrosine	1977
L-dopa: selective toxicity for melanoma cells in vitro. Science (New York, N.Y.), 1977, Jul-29, Volume: 197, Issue:4302 Topics: Cell Division; Cell Line; Levodopa; Melanoma; Pigmentation	1977
l-Dopa methyl ester as a new antitumour agent. Nature, 1977, Oct-06, Volume: 269, Issue:5628 Topics: Animals; DNA, Neoplasm; Leukemia, Experimental; Levodopa; Melanoma; Mice; Neoplasms, Experimental	1977
The effect of L-dopa, noradrenalin and adrenalin on P-388 mouse leukemia, B-16 mouse melanoma and E 0771 mammary carcinoma. Experientia, 1975, Jan-15, Volume: 31, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Epinephrine; Female; Leukemia, Experimental; Levodopa; Mammary Neoplasms, Experimental; Melanoma; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Norepinephrine	1975
[Letter: Malignant melanoma during treatment with levodopa]. La Nouvelle presse medicale, 1975, May-03, Volume: 4, Issue:18 Topics: Aged; Biopsy; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Parkinson Disease, Secondary; Skin Neoplasms	1975
Lid melanoma and parkinsonism. The British journal of ophthalmology, 1992, Volume: 76, Issue:4 Topics: Aged; Eyelid Neoplasms; Female; Humans; Levodopa; Melanoma; Parkinson Disease	1992
L-dopa binding sites in rodent melanoma cells. Biochimica et biophysica acta, 1992, Aug-25, Volume: 1139, Issue:4 Topics: Animals; Binding Sites; Carrier Proteins; Cell Membrane; Cell Nucleus; Cricetinae; Levodopa; Melanoma; Membrane Proteins; Mice; Tumor Cells, Cultured	1992
Impaired levodopa response in Parkinson's disease during melanoma therapy. Clinical neuropharmacology, 1992, Volume: 15, Issue:1 Topics: Adult; Dacarbazine; Dopamine; Drug Interactions; Humans; Levodopa; Male; Melanins; Melanoma; Parkinson Disease; Skin Neoplasms	1992
Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols. Biochimica et biophysica acta, 1991, Aug-06, Volume: 1074, Issue:3 Topics: Anions; Catalase; Chromatography, DEAE-Cellulose; Humans; Hydrogen Peroxide; Indolequinones; Indoles; Levodopa; Melanoma; Monophenol Monooxygenase; Oxidation-Reduction; Quinones; Substrate Specificity; Sulfhydryl Compounds; Superoxides	1991
Hydrogen peroxide as a mediator of dopac-induced effects on melanoma cells. The Journal of investigative dermatology, 1991, Volume: 96, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Catalase; Cell Line; Humans; Hydrogen Peroxide; Levodopa; Melanins; Melanoma; Monophenol Monooxygenase; Phenylacetates	1991
Molecular mechanism of tyrosinase regulation by L-dopa in hamster melanoma cells. Life sciences, 1991, Volume: 48, Issue:21 Topics: Animals; Cloning, Molecular; Cricetinae; Drug Administration Schedule; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Intracellular Fluid; Levodopa; Melanins; Melanoma; Monophenol Monooxygenase; Protein Biosynthesis; RNA, Messenger; Tumor Cells, Cultured	1991
L-tyrosine-binding proteins on melanoma cells. In vitro cellular & developmental biology : journal of the Tissue Culture Association, 1991, Volume: 27A, Issue:9 Topics: Animals; Antibodies; Blotting, Western; Carbon Radioisotopes; Chromatography, Affinity; Cricetinae; Levodopa; Melanoma; Molecular Weight; Monophenol Monooxygenase; Phenylalanine; Protein Binding; Tumor Cells, Cultured; Tyrosine	1991
[Heterogeneity of tyrosinases isolated from rat skin, normal human skin, and human melanoma tumors]. Biokhimiia (Moscow, Russia), 1991, Volume: 56, Issue:6 Topics: Animals; Blotting, Western; Chromatography, Liquid; Electrophoresis, Polyacrylamide Gel; Humans; Isoelectric Focusing; Isoenzymes; Kinetics; Levodopa; Melanoma; Monophenol Monooxygenase; Oxidation-Reduction; Rats; Skin; Skin Neoplasms	1991
The use of L-dopa and carbidopa in metastatic malignant melanoma. The Journal of investigative dermatology, 1991, Volume: 96, Issue:1 Topics: Carbidopa; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms	1991
The effect of L-dopa on the potentiation of radiation damage to human melanoma cells. British journal of cancer, 1990, Volume: 62, Issue:1 Topics: Cell Cycle; DNA Damage; Dose-Response Relationship, Radiation; Female; HeLa Cells; Humans; Levodopa; Melanoma; Radiation Tolerance	1990
Development of two malignant melanomas during administration of levodopa. Acta dermato-venereologica, 1985, Volume: 65, Issue:6 Topics: Aged; Humans; Levodopa; Male; Melanoma; Parkinson Disease; Time Factors	1985
Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine. Cancer research, 1989, May-01, Volume: 49, Issue:9 Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Glutathione; Humans; Levodopa; Melanoma; Methionine Sulfoximine; Tumor Cells, Cultured	1989
Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells. The Journal of investigative dermatology, 1989, Volume: 92, Issue:5 Suppl Topics: Animals; DNA; Dopamine; Dose-Response Relationship, Drug; Humans; Levodopa; Melanocytes; Melanoma; Mice; Skin Neoplasms	1989
Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells. Biochemical and biophysical research communications, 1987, Jun-15, Volume: 145, Issue:2 Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Isomerism; Levodopa; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Monophenol Monooxygenase; Phosphorylation; Tyrosine 3-Monooxygenase	1987
Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells. Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:1 Topics: Cell Cycle; Cell Survival; DNA, Neoplasm; Dopamine; Humans; Levodopa; Melanins; Melanoma; Oxidation-Reduction; RNA, Neoplasm; Superoxide Dismutase; Tumor Cells, Cultured	1989
Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa. Cancer research, 1986, Volume: 46, Issue:2 Topics: Animals; Biological Transport; Cell Survival; Cells, Cultured; Levodopa; Melanins; Melanoma; Mice; Monophenol Monooxygenase; Phosphorylation; Solubility	1986
Mechanism of antitumoral activity of catechols in culture. Biochemical pharmacology, 1987, Feb-15, Volume: 36, Issue:4 Topics: Anisoles; Butylated Hydroxyanisole; Catalase; Catechols; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Culture Media; Humans; Hydroquinones; Leukemia, Erythroblastic, Acute; Levodopa; Lymphoma; Melanoma; Monophenol Monooxygenase; Peroxidases; Resorcinols; Superoxide Dismutase; Time Factors	1987
A hypothesis on the etiology of malignant melanoma: the role of chemicals interfering with melanin synthesis. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:8 Topics: 9,10-Dimethyl-1,2-benzanthracene; Female; Humans; Levodopa; Male; Melanoma; Occupational Diseases; Polychlorinated Biphenyls; Skin Neoplasms; Sunlight	1987
Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa. Journal of cell science, 1988, Volume: 89 ( Pt 3) Topics: Animals; Cricetinae; Levodopa; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Tumor Cells, Cultured; Tyrosine	1988
13C solid-state cross polarization/magic-angle-spinning nuclear magnetic resonance spectra of natural and synthetic melanins. Pigment cell research, 1988, Volume: 1, Issue:5 Topics: Animals; Carbon Isotopes; Choroid; Horse Diseases; Horses; Levodopa; Magnetic Resonance Spectroscopy; Melanins; Melanoma; Oxidation-Reduction; Tyrosine	1988
[Visualization of a lung metastatic lesion from malignant melanoma by N-isopropyl-p-123I-iodoamphetamine: usefulness of L-dopa load scintigraphy]. Kaku igaku. The Japanese journal of nuclear medicine, 1987, Volume: 24, Issue:7 Topics: Aged; Amphetamines; Female; Humans; Iofetamine; Levodopa; Lung Neoplasms; Melanoma; Nose Neoplasms; Radionuclide Imaging	1987
Inhibition of transformation by levodopa-carbidopa in lymphocytes derived from patients with melanoma. The Journal of investigative dermatology, 1987, Volume: 88, Issue:5 Topics: Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Lymphocyte Activation; Melanoma; Osmolar Concentration; Phytohemagglutinins	1987
The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro. The Journal of investigative dermatology, 1987, Volume: 88, Issue:5 Topics: Antineoplastic Agents; Catechols; Cell Division; Cell Line; Cell Survival; Cysteine; Dose-Response Relationship, Drug; Humans; Levodopa; Melanoma; Phenols; Time Factors	1987
Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:3 Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lung Neoplasms; Melanoma; Mice; Mice, Inbred Strains; Phenylalanine; Tyrosine	1986
Pretreatment effects on the uptake/retention kinetics of L-dopa in Harding-Passey melanoma. The Journal of investigative dermatology, 1986, Volume: 86, Issue:5 Topics: Adrenal Glands; Animals; Injections, Intraperitoneal; Kinetics; Levodopa; Melanoma; Metabolic Clearance Rate; Mice; Premedication	1986
Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation. Journal of the National Cancer Institute, 1985, Volume: 75, Issue:3 Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lipid Peroxides; Liver; Malondialdehyde; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Phenylalanine; Tyrosine	1985
The involvement of histidine at the active site of Harding-Passey mouse melanoma tyrosinase. Biochemistry international, 1985, Volume: 11, Issue:5 Topics: Animals; Binding Sites; Catechol Oxidase; Cell Line; Histidine; Hydrogen-Ion Concentration; Kinetics; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Oxidation-Reduction; Photochemistry	1985
Plasma L-dopa in the diagnosis of malignant melanoma. Clinical chemistry, 1986, Volume: 32, Issue:1 Pt 1 Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms	1986
Levodopa and melanoma: three cases and review of literature. Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:6 Topics: Aged; Female; Humans; Levodopa; Male; Melanoma; Parkinson Disease; Skin Neoplasms	1985
Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature. The American journal of medicine, 1985, Volume: 79, Issue:1 Topics: Female; Humans; Levodopa; Melanoma; Middle Aged; Nevus, Pigmented; Parkinson Disease; Skin Neoplasms	1985
Stimulation of pheomelanogenesis in cultured B16 melanoma cells by 4-tertiary butylcatechol. Biochemical pharmacology, 1985, Oct-01, Volume: 34, Issue:19 Topics: Animals; Catechols; Cell Line; Chromatography, High Pressure Liquid; Cysteinyldopa; Dose-Response Relationship, Drug; Glutathione; Kinetics; Levodopa; Melanins; Melanoma; Mice	1985
Metabolic characterization of three hamster melanoma variants. Neoplasma, 1985, Volume: 32, Issue:5 Topics: Animals; Cell Line; Citrates; Citric Acid; Citric Acid Cycle; Cricetinae; Glucose; Glutamine; Glycolysis; Levodopa; Melanoma; Mesocricetus; Pentose Phosphate Pathway	1985
[Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship]. Fortschritte der Medizin, 1974, Sep-26, Volume: 92, Issue:27 Topics: Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parkinson Disease; Skin Neoplasms; Tryptophan	1974